CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Berlin, Germany and 209 other locations
PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung cancer (NSCLC)....
Phase 2
Berlin, Germany and 126 other locations
A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung...
Phase 2
Berlin, Germany and 137 other locations
NSCLC comprises of approximately 84 percent (%) of all lung cancers and is often diagnosed at advanced stage due to poor prognosis....
Phase 2
Berlin, Germany and 57 other locations
in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung cancer...
Phase 3
Berlin, Germany and 205 other locations
of AZD9291 versus a standard of care epidermal growth factor receptor tyrosine kinase inhibitor in patients with locally advanced or Metastatic Non...
Phase 3
Berlin, Germany and 168 other locations
The purpose of this study is to evaluate efficacy and safety of osimertinib (tablet) in combination with Datopotamab Deruxtecan (i.v. infusion) compa...
Phase 3
Berlin, Germany and 67 other locations
provides improved patient outcomes compared to pembrolizumab alone in patients with previously treated locally advanced or metastatic non-sm ...
Phase 2
Berlin, Germany and 32 other locations
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...
Phase 2
Berlin, Germany and 252 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...
Phase 3
Berlin, Germany and 283 other locations
Clinical trials
Research sites
Resources
Legal